Sebastian Kramberg

Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice

Martin Faehling, B. Schwenk, Sebastian Kramberg et al. · Oncotarget · 2017 · 34 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Immuno-Oncological Treatment and Tumor Mass in Non-Small Cell Lung Cancer: Case-Control Analysis of Overall Survival in Routine Clinical Practice

Martin Faehling, M. Kopp, B. Schwenk et al. · Oncology · 2019 · 21 citations

Medicine, Immunology, Oncology +17

Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice

Martin Faehling, B. Schwenk, Sebastian Kramberg et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 12 citations · Full text

Medicine, Oncology, Surgery +13

Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option

Martin Faehling, Sabine Fallscheer, Sebastian Kramberg et al. · European Journal of Cancer · 2021 · 12 citations

Medicine, Oncology, Surgery +17